First Xibrom generic introduced by Mylan
Mylan Inc. has released bromfenac ophthalmic solution 0.09%, which alleviates swelling and pain caused by cataract surgery. The company said this week that the twice daily administration product, rolled out by its Mylan Pharmaceuticals Inc.